Skip to main content
Journal cover image

Temporary autonomic modulation with botulinum toxin type A to reduce atrial fibrillation after cardiac surgery.

Publication ,  Journal Article
Waldron, NH; Cooter, M; Haney, JC; Schroder, JN; Gaca, JG; Lin, SS; Sigurdsson, MI; Fudim, M; Podgoreanu, MV; Stafford-Smith, M; Milano, CA ...
Published in: Heart Rhythm
February 2019

BACKGROUND: Postoperative atrial fibrillation (POAF) frequently complicates cardiac surgery and is associated with worse outcomes. The cardiac autonomic nervous system is implicated in the pathogenesis of POAF. OBJECTIVE: The purpose of this study was to determine the efficacy and safety of selective cardiac autonomic modulation in preventing POAF. METHODS: In this randomized, double-blind, placebo-controlled trial, adults undergoing cardiac surgery were randomized 1:1 to intraoperative injection of 250 units onabotulinumtoxinA (botulinum toxin type A [BoNTA]) or placebo into epicardial fat pads. The study was powered to detect a 40% reduction in relative risk of POAF. Time to first episode of in-hospital POAF was the primary outcome, evaluated in patients receiving injection. Additionally, incidence of POAF, length of stay (LOS), and adverse events were examined. RESULTS: The trial assigned 145 patients to injection, 15 of whom were dropped before treatment, leaving 130 patients for analysis. Overall, 36.5% (23/63) of BoNTA-treated patients developed POAF compared with 47.8% (32/67) of placebo-treated patients. The time-to-event analysis revealed a hazard ratio of 0.69 (95% confidence interval 0.41-1.19; P = .18) for the BoNTA vs placebo arm. There were no significant differences in postoperative hospital LOS (median [interquartile range] 6.0 [3.4] vs 6.2 [3.7] days; P = .51) or adverse events prolonging LOS (27/63 [42.9%] vs 30/67 [44.8%]; P = .83) in patients receiving BoNTA vs placebo. CONCLUSION: Epicardial injection of onabotulinumtoxinA was without discernible adverse effects, but we failed to detect a significant difference in risk of POAF. Future large-scale studies of epicardial onabotulinumtoxinA injection as a potential POAF prevention strategy should be designed to study smaller, but clinically meaningful, treatment effects.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Heart Rhythm

DOI

EISSN

1556-3871

Publication Date

February 2019

Volume

16

Issue

2

Start / End Page

178 / 184

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Time Factors
  • Postoperative Complications
  • Neurotoxins
  • Male
  • Humans
  • Follow-Up Studies
  • Female
  • Double-Blind Method
  • Cardiovascular System & Hematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Waldron, N. H., Cooter, M., Haney, J. C., Schroder, J. N., Gaca, J. G., Lin, S. S., … Mathew, J. P. (2019). Temporary autonomic modulation with botulinum toxin type A to reduce atrial fibrillation after cardiac surgery. Heart Rhythm, 16(2), 178–184. https://doi.org/10.1016/j.hrthm.2018.08.021
Waldron, Nathan H., Mary Cooter, John C. Haney, Jacob N. Schroder, Jeffrey G. Gaca, Shu S. Lin, Martin I. Sigurdsson, et al. “Temporary autonomic modulation with botulinum toxin type A to reduce atrial fibrillation after cardiac surgery.Heart Rhythm 16, no. 2 (February 2019): 178–84. https://doi.org/10.1016/j.hrthm.2018.08.021.
Waldron NH, Cooter M, Haney JC, Schroder JN, Gaca JG, Lin SS, et al. Temporary autonomic modulation with botulinum toxin type A to reduce atrial fibrillation after cardiac surgery. Heart Rhythm. 2019 Feb;16(2):178–84.
Waldron, Nathan H., et al. “Temporary autonomic modulation with botulinum toxin type A to reduce atrial fibrillation after cardiac surgery.Heart Rhythm, vol. 16, no. 2, Feb. 2019, pp. 178–84. Pubmed, doi:10.1016/j.hrthm.2018.08.021.
Waldron NH, Cooter M, Haney JC, Schroder JN, Gaca JG, Lin SS, Sigurdsson MI, Fudim M, Podgoreanu MV, Stafford-Smith M, Milano CA, Piccini JP, Mathew JP. Temporary autonomic modulation with botulinum toxin type A to reduce atrial fibrillation after cardiac surgery. Heart Rhythm. 2019 Feb;16(2):178–184.
Journal cover image

Published In

Heart Rhythm

DOI

EISSN

1556-3871

Publication Date

February 2019

Volume

16

Issue

2

Start / End Page

178 / 184

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Time Factors
  • Postoperative Complications
  • Neurotoxins
  • Male
  • Humans
  • Follow-Up Studies
  • Female
  • Double-Blind Method
  • Cardiovascular System & Hematology